Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ARSA |
| Upstream (Parents) |
|---|
| (<<) ADAM19 → ARSA |
| (<<) CD4 → ARSA |
| (<<) CISH → ARSA |
| (<<) EHD1 → ARSA |
| (<<) FLJ35934 → ARSA |
| (<<) GNAI2 → ARSA |
| (<<) GRN → ARSA |
| (<<) ITGB7 → ARSA |
| (<<) ITGB8 → ARSA |
| (<<) LIMK1 → ARSA |
| (<<) MKNK2 → ARSA |
| (<<) NFAT5 → ARSA |
| (<<) OAF → ARSA |
| (<<) PIP5K1C → ARSA |
| (<<) POU3F3 → ARSA |
| (<<) PRKCD → ARSA |
| (<<) PRR5 → ARSA |
| (<<) PTK2B → ARSA |
| (<<) RHOG → ARSA |
| (<<) RXRA → ARSA |
| (<<) ST3GAL2 → ARSA |
| (<<) STAT5B → ARSA |
| (<<) STAT6 → ARSA |
| (<<) TMEM175 → ARSA |
| (<<) VAV1 → ARSA |
| (<<) VEGFB → ARSA |
| Downstream (Children) |
|---|
| ARSA → APC2 (>>) |
| ARSA → BCL3 (>>) |
| ARSA → DNM1L (>>) |
| ARSA → DUSP5 (>>) |
| ARSA → GYS1 (>>) |
| ARSA → LOC642031 (>>) |
| ARSA → MAP2K5 (>>) |
| ARSA → PTGS1 (>>) |
| ARSA → SGCA (>>) |
| ARSA → TCEB1 (>>) |
